Oak Street Health, Inc. (NYSE:OSH – Get Rating) insider Geoffrey M. Price sold 50,000 shares of the business’s stock in a transaction that occurred on Tuesday, January 10th. The stock was sold at an average price of $29.74, for a total value of $1,487,000.00. Following the completion of the sale, the insider now directly owns 3,824,863 shares in the company, valued at $113,751,425.62. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link.
Oak Street Health Price Performance
NYSE:OSH opened at $30.05 on Friday. The firm has a market capitalization of $7.30 billion, a price-to-earnings ratio of -13.24 and a beta of 2.18. Oak Street Health, Inc. has a one year low of $13.29 and a one year high of $30.89. The business has a fifty day moving average price of $21.70 and a 200-day moving average price of $23.57.
Oak Street Health (NYSE:OSH – Get Rating) last posted its quarterly earnings data on Monday, November 7th. The company reported ($0.56) EPS for the quarter, topping the consensus estimate of ($0.63) by $0.07. The firm had revenue of $545.70 million during the quarter, compared to analyst estimates of $540.28 million. Oak Street Health had a negative return on equity of 1,883.59% and a negative net margin of 26.04%. On average, equities research analysts expect that Oak Street Health, Inc. will post -2.26 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of analysts have recently commented on OSH shares. UBS Group dropped their price target on Oak Street Health from $28.00 to $21.00 and set a “neutral” rating on the stock in a research report on Friday, January 6th. Canaccord Genuity Group lowered their price objective on Oak Street Health from $32.00 to $27.00 in a research report on Wednesday, November 9th. Morgan Stanley raised Oak Street Health from an “equal weight” rating to an “overweight” rating in a research report on Monday, November 14th. SVB Leerink upped their price objective on Oak Street Health from $23.00 to $33.00 and gave the company a “market perform” rating in a research report on Tuesday. Finally, Raymond James raised Oak Street Health from a “market perform” rating to an “outperform” rating and set a $35.00 price objective on the stock in a research report on Thursday. One investment analyst has rated the stock with a sell rating, five have given a hold rating and seven have given a buy rating to the stock. Based on data from MarketBeat.com, Oak Street Health has a consensus rating of “Hold” and an average target price of $31.07.
Institutional Investors Weigh In On Oak Street Health
Several hedge funds and other institutional investors have recently modified their holdings of the stock. Heritage Wealth Management LLC bought a new position in Oak Street Health in the 2nd quarter worth $58,000. Captrust Financial Advisors boosted its holdings in Oak Street Health by 114.5% in the 1st quarter. Captrust Financial Advisors now owns 2,688 shares of the company’s stock worth $72,000 after buying an additional 1,435 shares during the period. PNC Financial Services Group Inc. boosted its holdings in Oak Street Health by 1,496.3% in the 1st quarter. PNC Financial Services Group Inc. now owns 3,480 shares of the company’s stock worth $93,000 after buying an additional 3,262 shares during the period. MetLife Investment Management LLC bought a new position in Oak Street Health in the 1st quarter worth $159,000. Finally, Wealthspire Advisors LLC bought a new position in Oak Street Health in the 2nd quarter worth $164,000. 92.04% of the stock is currently owned by hedge funds and other institutional investors.
About Oak Street Health
Oak Street Health, Inc, together with its subsidiaries, offers healthcare services to the patients in the United States. The company operates primary care centers for Medicare beneficiaries. As of December 31, 2021, it operated 129 centers in 19 states, including Illinois, Michigan, Pennsylvania, Ohio, and Texas.
Featured Articles
Receive News & Ratings for Oak Street Health Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Oak Street Health and related companies with MarketBeat.com’s FREE daily email newsletter.
Source: news.google.com
